Ten years of the manufacturing classification system: a review of literature applications and an extension of the framework to continuous manufacture

Leane, Michael, Pitt, Kendal, Reynolds, Gavin, Tantuccio, Anthony, Moreton, Chris, Crean, Abina, Kleinebudde, Peter, Carlin, Brian, Gamble, John, Gamlen, Michael, Stone, Elaine, Kuentz, Martin, Gururajan, Bindhu, Khimyak, Yaroslav Z. ORCID: https://orcid.org/0000-0003-0424-4128, Van Snick, Bernd, Andersen, Sune, Peter, Stefanie and Sheelan, Stephen (2024) Ten years of the manufacturing classification system: a review of literature applications and an extension of the framework to continuous manufacture. Pharmaceutical Development and Technology, 29 (5). pp. 395-414. ISSN 1083-7450

[thumbnail of Third Paper Final Submission Version] PDF (Third Paper Final Submission Version) - Accepted Version
Restricted to Repository staff only until 6 May 2025.

Request a copy


The MCS initiative was first introduced in 2013. Since then, two MCS papers have been published: the first proposing a structured approach to consider the impact of drug substance physical properties on manufacturability and the second outlining real world examples of MCS principles. By 2023, both publications had been extensively cited by over 240 publications. This article firstly reviews this citing work and considers how the MCS concepts have been received and are being applied. Secondly, we will extend the MCS framework to continuous manufacture. The review structure follows the flow of drug product development focussing first on optimisation of API properties. The exploitation of links between API particle properties and manufacturability using large datasets seems particularly promising. Subsequently, applications of the MCS for formulation design include a detailed look at the impact of percolation threshold, the role of excipients and how other classification systems can be of assistance. The final review section focusses on manufacturing process development, covering the impact of strain rate sensitivity and modelling applications. The second part of the paper focuses on continuous processing proposing a parallel MCS framework alongside the existing batch manufacturing guidance. Specifically, we propose that continuous direct compression can accommodate a wider range of API properties compared to its batch equivalent.

Item Type: Article
Uncontrolled Keywords: granulation,manufacturing,pharmaceutical,process development,tablet,batch,capsule,continuous manufacturing,development,formulation,pharmaceutical science ,/dk/atira/pure/subjectarea/asjc/3000/3003
Faculty \ School: Faculty of Science > School of Pharmacy
UEA Research Groups: Faculty of Science > Research Groups > Pharmaceutical Materials and Soft Matter
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 08 Jul 2024 13:31
Last Modified: 14 Jul 2024 06:34
URI: https://ueaeprints.uea.ac.uk/id/eprint/95826
DOI: 10.1080/10837450.2024.2342953

Actions (login required)

View Item View Item